A multicenter phase II trial of paclitaxel, carboplatin, and cetuximab followed by chemoradiotherapy in patients with unresectable locally advanced squamous cell carcinoma of the head and neck.

Tomohiro EnokidaTakenori OgawaAkihiro HommaKenji OkamiShujiro MinamiAyako NakanomeYasushi ShimizuDaisuke MakiYuri UedaTakao FujisawaAtsushi MotegiAkira OhkoshiJun TaguchiKoji EbisumotoShogo NomuraSusumu OkanoMakoto Tahara

Published in: Cancer medicine (2020)

PCE as IC was feasible, with promising efficacy and no effect on compliance with subsequent CRT in unresectable LA-SCCHN.

Keyphrases

locally advanced
squamous cell carcinoma
phase ii study
rectal cancer
neoadjuvant chemotherapy
radiation therapy
open label
lymph node metastasis
cross sectional
cardiac resynchronization therapy
double blind
left ventricular
phase iii
study protocol